Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.98 |
| ▸ | CPB2 | Q96IY4 | 3/20 | 0.53 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.47 |
| ▸ | ITGB2 | P05107 | 3/20 | 0.47 |
| ▸ | ICAM1 | P05362 | 3/20 | 0.47 |
| ▸ | ITGAL | P20701 | 3/20 | 0.47 |
| ▸ | GHSR | Q92847 | 1/20 | 0.46 |
| ▸ | CPB1 | P15086 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 2/20 | 0.44 |
| ▸ | CA2 | P00918 | 2/20 | 0.44 |
| ▸ | REN | P00797 | 2/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.44 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28851961 | 1.00 | SLC15A2 (0.98) | SLC15A2CPB2SLC6A5ITGB2ICAM1 | |
| SCHEMBL30175135 | 0.99 | SLC15A2 (1.00) | SLC15A2CPB2SLC6A5ITGB2ICAM1 | |
| SCHEMBL22462015 | 0.99 | SLC15A2 (1.00) | SLC15A2CPB2SLC6A5ITGB2ICAM1 | |
| SCHEMBL19087235 | 0.99 | SLC15A2 (1.00) | SLC15A2CPB2SLC6A5ITGB2ICAM1 | |
| Acetic Acid SCHEMBL31696243 | 0.96 | SLC15A2 (0.94) | SLC15A2CPB2SLC6A5ITGB2ICAM1 | |
| SCHEMBL29349986 | 0.96 | SLC15A2 (0.94) | SLC15A2CPB2SLC6A5ITGB2ICAM1 | |
| SCHEMBL29352785 | 0.95 | SLC15A2 (0.92) | SLC15A2CPB2SLC6A5ITGB2ICAM1 | |
| Acetic Acid SCHEMBL29360257 | 0.95 | SLC15A2 (0.92) | SLC15A2CPB2SLC6A5ITGB2ICAM1 | |
| SCHEMBL29351224 | 0.95 | SLC15A2 (0.92) | SLC15A2CPB2SLC6A5ITGB2ICAM1 | |
| SCHEMBL29397091 | 0.89 | SLC15A2 (0.82) | SLC15A2CPB2SLC6A5ITGB2ICAM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113301910-B | Skin rejuvenation and healing mixtures of peptide components and uses thereof | 环球科技创新有限股份公司 | 2023-02-03 | — | — | CN | claimed |
| US-20260108452-A1 | REGENERATIVE COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME | INVO Aesthetics Inc. (US) | 2026-04-23 | — | — | US | disclosed |
| US-20260077092-A1 | INJECTABLE COLLAGEN IMPLANTS AND COMPOSITIONS AND RELATED SYSTEMS, AND METHODS OF PREPARATION AND USE THEREOF | Miach Orthopaedics, Inc. (US) | 2026-03-19 | — | — | US | disclosed |
| US-20260077091-A1 | INJECTABLE COLLAGEN IMPLANTS AND COMPOSITIONS AND RELATED SYSTEMS, AND METHODS OF PREPARATION AND USE THEREOF | Miach Orthopaedics, Inc. (US) | 2026-03-19 | — | — | US | disclosed |
| US-20260077094-A1 | INJECTABLE COLLAGEN IMPLANTS AND COMPOSITIONS AND RELATED SYSTEMS, AND METHODS OF PREPARATION AND USE THEREOF | Miach Orthopaedics, Inc. (US) | 2026-03-19 | — | — | US | disclosed |
| US-20260077093-A1 | INJECTABLE COLLAGEN IMPLANTS AND COMPOSITIONS AND RELATED SYSTEMS, AND METHODS OF PREPARATION AND USE THEREOF | Miach Orthopaedics, Inc. (US) | 2026-03-19 | — | — | US | disclosed |
| US-20260077090-A1 | INJECTABLE COLLAGEN IMPLANTS AND COMPOSITIONS AND RELATED SYSTEMS, AND METHODS OF PREPARATION AND USE THEREOF | Miach Orthopaedics, Inc. (US) | 2026-03-19 | — | — | US | disclosed |
| US-20260077095-A1 | INJECTABLE COLLAGEN IMPLANTS AND COMPOSITIONS AND RELATED SYSTEMS, AND METHODS OF PREPARATION AND USE THEREOF | Miach Orthopaedics, Inc. (US) | 2026-03-19 | — | — | US | disclosed |
| US-20260027257-A1 | INJECTABLE COLLAGEN IMPLANTS AND COMPOSITIONS AND RELATED SYSTEMS, AND METHODS OF PREPARATION AND USE THEREOF | Miach Orthopaedics, Inc. (US) | 2026-01-29 | — | — | US | disclosed |
| US-20260027259-A1 | INJECTABLE COLLAGEN IMPLANTS AND COMPOSITIONS AND RELATED SYSTEMS, AND METHODS OF PREPARATION AND USE THEREOF | Miach Orthopaedics, Inc. (US) | 2026-01-29 | — | — | US | disclosed |
| CN-113769066-B | Composition for promoting wound healing and preparation method and application thereof | 成都英普博集生物科技有限公司 | 2023-10-27 | — | — | CN | disclosed |
| CN-116785194-A | Milk exosome loaded alkylated cosmetic peptide and application thereof in cosmetics | 天津外泌体科技有限公司 | 2023-09-22 | — | — | CN | disclosed |
| EP-4226918-A1 | PHARMACEUTICAL SINGLE DOSAGE FORM FOR ORAL DELIVERY OF PEPTIDES | Majewski, Filip (PL) | 2023-08-16 | — | — | EP | disclosed |
| CN-115944710-A | Blue copper peptide composition and application thereof | 上海湃肽生物科技有限公司 | 2023-04-11 | — | — | CN | disclosed |
| CN-113301910-B | Skin rejuvenation and healing mixtures of peptide components and uses thereof | 环球科技创新有限股份公司 | 2023-02-03 | — | — | CN | disclosed |
| CN-111329779-B | Active peptide composition for promoting hair growth and application thereof | 烟台中科恩吉科创新产业园管理有限公司 | 2022-09-13 | — | — | CN | disclosed |
| EP-3334413-B1 | A DELIVERY DEVICE | PTT HOLDING APS (DK) | 2022-05-18 | — | — | EP | disclosed |
| US-11331305-B2 | Peptides for skin rejuvenation and methods of using the same | ANTEIS SA (CH) | 2022-05-17 | — | — | US | disclosed |
| CN-113769066-A | Composition for promoting wound healing and preparation method and application thereof | 成都英普博集生物科技有限公司 | 2021-12-10 | — | — | CN | disclosed |
| CN-113679824-A | Composition with antioxidant and anti-inflammatory functions | 成都英普博集生物科技有限公司 | 2021-11-23 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260027257-A1 | INJECTABLE COLLAGEN IMPLANTS AND COMPOSITIONS AND RELATED SYSTEMS, AND METHODS OF PREPARATION AND USE THEREOF | COL2A1, MMP1, COL1A1 | SLC15A2 1800/4885CPB2 2858/4885SLC6A5 1356/4885 |
| US-20260077090-A1 | INJECTABLE COLLAGEN IMPLANTS AND COMPOSITIONS AND RELATED SYSTEMS, AND METHODS OF PREPARATION AND USE THEREOF | COL2A1, COL1A1, MMP13 | SLC15A2 1834/4885CPB2 2506/4885SLC6A5 996/4885 |
| US-20260077095-A1 | INJECTABLE COLLAGEN IMPLANTS AND COMPOSITIONS AND RELATED SYSTEMS, AND METHODS OF PREPARATION AND USE THEREOF | COL2A1, MMP1, COL1A1 | SLC15A2 1216/4885CPB2 2418/4885SLC6A5 186/4885 |
| US-20260077094-A1 | INJECTABLE COLLAGEN IMPLANTS AND COMPOSITIONS AND RELATED SYSTEMS, AND METHODS OF PREPARATION AND USE THEREOF | COL2A1, COL1A1, MMP1 | SLC15A2 503/4885CPB2 2829/4885SLC6A5 122/4885 |
| US-11331305-B2 | Peptides for skin rejuvenation and methods of using the same | CUTA, PLOD3, MMP13 | SLC15A2 1358/4885CPB2 1241/4885SLC6A5 2755/4885 |
| US-20260077091-A1 | INJECTABLE COLLAGEN IMPLANTS AND COMPOSITIONS AND RELATED SYSTEMS, AND METHODS OF PREPARATION AND USE THEREOF | COL2A1, COL1A1, COL14A1 | SLC15A2 2255/4885CPB2 2970/4885SLC6A5 1444/4885 |
| US-20260108452-A1 | REGENERATIVE COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME | FGF1, FGF2, HGF | SLC15A2 1759/4885CPB2 3396/4885SLC6A5 4690/4885 |
| US-20260027259-A1 | INJECTABLE COLLAGEN IMPLANTS AND COMPOSITIONS AND RELATED SYSTEMS, AND METHODS OF PREPARATION AND USE THEREOF | COL2A1, COL1A1, MMP1 | SLC15A2 2620/4885CPB2 3041/4885SLC6A5 1920/4885 |
| US-20260077092-A1 | INJECTABLE COLLAGEN IMPLANTS AND COMPOSITIONS AND RELATED SYSTEMS, AND METHODS OF PREPARATION AND USE THEREOF | COL2A1, COL1A1, MMP1 | SLC15A2 573/4885CPB2 2275/4885SLC6A5 102/4885 |
| US-20260077093-A1 | INJECTABLE COLLAGEN IMPLANTS AND COMPOSITIONS AND RELATED SYSTEMS, AND METHODS OF PREPARATION AND USE THEREOF | COL2A1, MMP1, COL1A1 | SLC15A2 998/4885CPB2 2612/4885SLC6A5 156/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.